Pediatricians and other experts answer questions about the COVID-19 vaccines.
Infectious disease epidemiologist Jessica Malaty Rivera, MS explains that the risk for myocarditis from the COVID-19 vaccine is very rare relative to the risk presented by COVID.
So, very encouragingly, in the pediatric trial that involved 5 to 11-year-olds, there were no reports of myocarditis and pericarditis. Now in the pediatric trial that involved kids who are 12-16, there were a couple of cases of myocarditis that were reported those cases mostly resolved. But what we have to remember too is that compared to myocarditis induced by the virus that risk is so much greater than it is from getting it from the vaccine.
We know that the virus itself actually presents a much greater risk for issues of inflammation, myocarditis, pericarditis and multi-system inflammatory disease. And, so because of that, we know that to get vaccinated actually reduces the risk of myocarditis. In the incidences that myocarditis has been reported, they have been mild and resolved and have not involved any sort of acute complications as a result. And, so, because of that, pediatricians of even adolescent boys will say that the benefits of vaccination outweigh the risks.